Delivery Order SPE2DB20D3103-SPE2DB22FL4B9

Award Date 10/21/21
Potential Completion Date 10/22/21
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,439.74 firm fixed-price delivery order is for the supply of 1,000 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has an ultimate completion date of February 5, 2024 and was awarded on February 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award, with a ceiling value of $5,396.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,550,336 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC...
This federal contract award, valued at $3,891.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count bottles. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as...
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRAJ2, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count quantities, with a ceiling value of $1,422.08. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
This federal contract award, with ID SPE2DB22D3016|SPE2DB23FBSW8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,792.08 Firm Fixed Price Delivery Order contract is for the supply of 4562252693 - Pantoprazole Sodium Delayed-Release 40 mg Tablets in 90-count packages. The contract has an ultimate completion date of September 21, 2023. This award is not designated with any set-aside requirements, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,169.21, is for the delivery of Pantoprazole Sodium Delayed-Release Tablets, 40 mg, in 1,000-count quantities. This is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up...
This contract award for $3,710.28 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,960,079 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 19, 2022. The award was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB23FV44Q, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4,562,252 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a ceiling value of $1,325.52 and a completion date of September 21, 2023. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,201.72 contract is for the delivery of 4,563,432,587 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count bottles. The contract has an ultimate completion date of January 25, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,141.71, is for the delivery of 4,563,619,057 units of the prescription drug Pantoprazole Sodium Delayed Release 40 mg Tablets in quantities of 1,000. The contract has a firm fixed price and an ultimate completion date of February 12, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FL4B9
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to supply 1,000 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The $1,317.57 contract has an ultimate completion date of October 22, 2021. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is not designated with a set-aside requirement, indicating open competition. In addition to the DLA contract, Cencora, Inc. maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 12:00 PM